Skip to content
Delayed ~15 min

OVID OVID THERAPEUTICS

Health Care · Russell 2000

Next earnings: Wed 11 Nov 2026 · estimated

What 17 analyst firms say about OVID THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

2.85 USD+0.27 (+10.47%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+99.0%to the avg target 5.67 USD+2.82 USD
Buy 15 · Hold 1 · Sell 0

16 rated views · 17 analyst/firm records · 17 firms

Latest report15 Oct 2026avg report date 8 Jul
Target rangeLowest to highest analyst target, not a forecast

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 9 reports on OVID from 8 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 2 raised their price target, 2 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: HC Wainwright raised its target from $4.00 (set 9 Apr 2026) to $5.00 on 11 Sep 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesMadison El-SaadiBuy21 Jul 20265.00 USD
BTIGThomas ShraderBuy26 Mar 20264.00 USD
Cantor FitzgeraldImogen MansfieldBuy9 Oct 2026—
GuggenheimDelma CaiatiBuy6 Oct 20267.00 USD
H.C. WainwrightRaghuram SelvarajuBuy11 Sep 20265.00 USD
Leerink PartnersMarc GoodmanBuy19 Mar 20265.00 USD
Lifesci CapitalFrancois BriseboisBuy24 Mar 20265.00 USD
Lucid Capital MarketsElemer PirosBuy5 May 20262.40 USD
OppenheimerKostas BiliourisBuy3 Aug 20269.00 USD
Roth CapitalBoobalan PachaiyappanBuy3 Sep 20268.00 USD
TD CowenRitu S BaralBuy24 Mar 2026—
UBSUnnamed analystBuy11 Sep 2026—
WedbushLaura ChicoBuy13 Aug 20267.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
William BlairMyles R MinterBuy19 Mar 2026—
Wolfe ResearchRudy LiBuy15 Oct 20265.00 USD
Data feed RESEARCHResearch TeamHold15 Jun 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:53 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.